FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Christopher Barnes

Research Profile

Chemicals & Drugs

Anatomy

Physiology

Disorders

Breast Neoplasms

Phenomena

Procedures

Co-author Network

Publications

TOP 3
Christopher J Barnes; Kazufumi Ohshiro; Rayala Suresh; Adel K El-Naggar; Rakesh Kumar
Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.
Filippo Acconcia; Christopher J Barnes; Rajesh R Singh; Amjad H Talukder; Rakesh Kumar
Phosphorylation-dependent regulation of nuclear localization and functions of integrin-linked kinase.
Rakesh Kumar; Anupama E Gururaj; Christopher J Barnes
p21-activated kinases in cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Christopher Barnes (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2007: Christopher J Barnes; Kazufumi Ohshiro; Rayala Suresh; Adel K El-Naggar; Rakesh Kumar
Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(14):4291-9.
2007: Filippo Acconcia; Christopher J Barnes; Rajesh R Singh; Amjad H Talukder; Rakesh Kumar
Phosphorylation-dependent regulation of nuclear localization and functions of integrin-linked kinase.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(16):6782-7.
2006: Rakesh Kumar; Anupama E Gururaj; Christopher J Barnes
p21-activated kinases in cancer.
Nature reviews. Cancer 2006;6(6):459-71.
2006: Filippo Acconcia; Christopher J Barnes; Rakesh Kumar
Estrogen and tamoxifen induce cytoskeletal remodeling and migration in endometrial cancer cells.
Endocrinology 2006;147(3):1203-12.
2006: Rayala Suresh; Amjad H Talukder; Seetharaman Balasenthil; Robbin Tharakan; Christopher J Barnes; Rui-An Wang; C Marcelo Aldaz; Sohaib Khan; Rakesh Kumar
P21-activated kinase 1 regulation of estrogen receptor-alpha activation involves serine 305 activation linked with serine 118 phosphorylation.
Cancer research 2006;66(3):1694-701.
2005: Rajesh R Singh; Christopher J Barnes; Amjad H Talukder; Suzanne A W Fuqua; Rakesh Kumar
Negative regulation of estrogen receptor alpha transactivation functions by LIM domain only 4 protein.
Cancer research 2005;65(22):10594-601.
2005: Ratna K Vadlamudi; Christopher J Barnes; Rayala Suresh; Feng Li; Seetharaman Balasenthil; Stevan Marcus; Holly V Goodson; Aysegul A Sahin; Rakesh Kumar
p21-activated kinase 1 regulates microtubule dynamics by phosphorylating tubulin cofactor B.
Molecular and cellular biology 2005;25(9):3726-36.
2005: Christopher J Barnes; Feng Li; Amjad H Talukder; Rakesh Kumar
Growth factor regulation of a 26S proteasomal subunit in breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(8):2868-74.
2004: Rakesh Kumar; Rui-An Wang; Christopher J Barnes
Coregulators and chromatin remodeling in transcriptional control.
Molecular carcinogenesis 2004;41(4):221-30.
2004: Anupama E Gururaj; Christopher J Barnes; Ratna K Vadlamudi; Rakesh Kumar
Regulation of phosphoglucomutase 1 phosphorylation and activity by a signaling kinase.
Oncogene 2004;23(49):8118-27.
2004: Seetharaman Balasenthil; Christopher J Barnes; Rayala Suresh; Rakesh Kumar
Estrogen receptor activation at serine 305 is sufficient to upregulate cyclin D1 in breast cancer cells.
FEBS letters 2004;567(2-3):243-7.
2004: Zhibo Yang; Christopher J Barnes; Rakesh Kumar
Human epidermal growth factor receptor 2 status modulates subcellular localization of and interaction with estrogen receptor alpha in breast cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(11):3621-8.
2004: Christopher J Barnes; Ratna K Vadlamudi; R Kumar
Novel estrogen receptor coregulators and signaling molecules in human diseases.
Cellular and molecular life sciences : CMLS 2004;61(3):281-91.
2004: Ratna K Vadlamudi; Feng Li; Christopher J Barnes; Rozita Bagheri-Yarmand; Rakesh Kumar
p41-Arc subunit of human Arp2/3 complex is a p21-activated kinase-1-interacting substrate.
EMBO reports 2004;5(2):154-60.
2004: Zhibo Yang; Rozita Bagheri-Yarmand; Rui-An Wang; Liana Adam; Vali Vassiliki Papadimitrakopoulou; Gary L Clayman; Adel El-Naggar; Reuben Lotan; Christopher J Barnes; Waun Ki Hong; Rakesh Kumar
The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 (Iressa) suppresses c-Src and Pak1 pathways and invasiveness of human cancer cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(2):658-67.
2004: Seetharaman Balasenthil; Aysegul A Sahin; Christopher J Barnes; Rui-An Wang; Richard G Pestell; Ratna K Vadlamudi; Rakesh Kumar
p21-activated kinase-1 signaling mediates cyclin D1 expression in mammary epithelial and cancer cells.
The Journal of biological chemistry 2004;279(2):1422-8.
2004: Christopher J Barnes; Rakesh Kumar
Biology of the epidermal growth factor receptor family.
Cancer treatment and research 2004;119():1-13.
2003: Christopher J Barnes; Rakesh Kumar
Epidermal growth factor receptor family tyrosine kinases as signal integrators and therapeutic targets.
Cancer metastasis reviews 2003;22(4):301-7.
2003: Zhibo Yang; Rozita Bagheri-Yarmand; Seetharaman Balasenthil; Gabriel Hortobagyi; Aysegul A Sahin; Christopher J Barnes; Rakesh Kumar
HER2 regulation of peroxisome proliferator-activated receptor gamma (PPARgamma) expression and sensitivity of breast cancer cells to PPARgamma ligand therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(8):3198-203.
2003: Christopher J Barnes; Ratna K Vadlamudi; Sandip K Mishra; Raymond Jacobsonr; Feng Li; Rakesh Kumar
Functional inactivation of a transcriptional corepressor by a signaling kinase.
Nature structural biology 2003;10(8):622-8.
2003: Christopher J Barnes; Rozita Bagheri-Yarmand; Mahitosh Mandal; Zhibo Yang; Gary L Clayman; Waun Ki Hong; Rakesh Kumar
Suppression of epidermal growth factor receptor, mitogen-activated protein kinase, and Pak1 pathways and invasiveness of human cutaneous squamous cancer cells by the tyrosine kinase inhibitor ZD1839 (Iressa).
Molecular cancer therapeutics 2003;2(4):345-51.
2003: Amjad H Talukder; Sandip K Mishra; Mahitosh Mandal; Seetharaman Balasenthil; Sonal Mehta; Aysegul A Sahin; Christopher J Barnes; Rakesh Kumar
MTA1 interacts with MAT1, a cyclin-dependent kinase-activating kinase complex ring finger factor, and regulates estrogen receptor transactivation functions.
The Journal of biological chemistry 2003;278(13):11676-85.
2002: Rakesh Kumar; Rui-An Wang; Abhijit Mazumdar; Amjad H Talukder; Mahitosh Mandal; Zhibo Yang; Rozita Bagheri-Yarmand; Aysegul Sahin; Gabriel Hortobagyi; Liana Adam; Christopher J Barnes; Ratna K Vadlamudi
A naturally occurring MTA1 variant sequesters oestrogen receptor-alpha in the cytoplasm.
Nature 2002;418(6898):654-7.
2002: Feng Li; Mahitosh Mandal; Sandip K Mishra; Christopher J Barnes; Rakesh Kumar
Heregulin promotes expression and subcellular redistribution of ADP-ribosylation factor 3.
FEBS letters 2002;524(1-3):49-53.
2002: Christopher J Barnes; Feng Li; Mahitosh Mandal; Zhibo Yang; Aysegul A Sahin; Rakesh Kumar
Heregulin induces expression, ATPase activity, and nuclear localization of G3BP, a Ras signaling component, in human breast tumors.
Cancer research 2002;62(5):1251-5.
2001: Feng Li; Mahitosh Mandal; Christopher J Barnes; Ratna K Vadlamudi; Rakesh Kumar
Growth factor regulation of the molecular chaperone calnexin.
Biochemical and biophysical research communications 2001;289(3):725-32.